References
- McCullough PA, Soman SS. Contrast-induced nephropathy. Crit Care Clin. 2005; 21: 261–280, [INFOTRIEVE], [CSA]
- Gleeson TG, Bulugahapitiya S. Contrast-induced nephropathy. Am J Roentgenol. 2004; 183: 1673–1689, [CSA]
- Gami AS, Garovic VD. Contrast nephropathy after coronary angiography. Mayo Clin Proc. 2004; 79: 211–219, [INFOTRIEVE], [CSA]
- Itoh Y, Yano T, Sendo T, Oishi R. Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media. J Pharmacol Sci. 2005; 97: 473–488, [INFOTRIEVE], [CSA], [CROSSREF]
- Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, Hill JA, Winniford M, Cohen MB, VanFossen DB. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int. 1995; 47: 254–261, [INFOTRIEVE], [CSA]
- Aspelin P, Aubry P, Fransson SG, Strasser R, Willenbrock R, Berg KJ. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003; 348: 491–499, [INFOTRIEVE], [CSA], [CROSSREF]
- Morcos SK, Thomsen HS. European Society of Urogenital Radiology guidelines on administering contrast media. Abdom Imaging. 2003; 28: 187–190, [INFOTRIEVE], [CSA], [CROSSREF]
- Goldenberg I, Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ. 2005; 172: 1461–1471, [INFOTRIEVE], [CSA]
- McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention; incidence, risk factors, and relationships to mortality. Am J Med. 1997; 103: 368–375, [INFOTRIEVE], [CSA], [CROSSREF]
- Bettmann MA. Contrast medium-induced nephropathy: critical review of the existing clinical evidence. Nephrol Dial Transplant 2005; 20(Suppl.)12–17, [CSA], [CROSSREF]
- Rich MW, Crecelius CA. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older: a prospective study. Arch Intern Med. 1990; 150: 1237–1242, [INFOTRIEVE], [CSA], [CROSSREF]
- Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, Singh M, Bell MR, Barsness GW, Mathew V, Garratt KN, Holmes DR, Jr. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002; 105: 2259–2264, [INFOTRIEVE], [CSA], [CROSSREF]
- Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int. 2005; 68: 14–22, [INFOTRIEVE], [CSA], [CROSSREF]
- Detrenis S, Meschi M, Musini S, Savazzi G. Lights and shadows on the pathogenesis of contrast-induced nephropathy: state of the art. Nephrol Dial Transplant. 2005; 20: 1542–1550, [INFOTRIEVE], [CSA], [CROSSREF]
- Heyman SN, Rosenberger C, Rosen S. Regional alterations in renal hemodynamics and oxygenation: a role in contrast medium-induced nephropathy. Nephrol Dial Transplant. 2005; 20(Suppl. 1)6–11, [CSA], [CROSSREF]
- Rudnick MR, Goldfarb S. Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality. Rev Cardiovasc Med. 2003; 4(Suppl. 5)28–33, [CSA]
- Nygren A, Ulfendahl HR. Effects of high- and low-osmolar contrast media on renal plasma flow and glomerular filtration rate in euvolaemic and dehydrated rats. Acta Radiol. 1989; 30: 383–389, [INFOTRIEVE], [CSA]
- Dangas G, Iakovou I, Nikolsky E, Aymong ED, Mintz GS, Kipshidze NN, Lansky AJ, Moussa I, Stone GW, Moses JW, Leon MB, Mehran R. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol. 2005; 95: 13–19, [INFOTRIEVE], [CSA], [CROSSREF]
- Marenzi G, Lauri G, Assanelli E, Campodonico J, De Metrio M, Marana I, Grazi M, Veglia F, Bartorelli AL. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2004; 44: 1780–1785, [INFOTRIEVE], [CSA], [CROSSREF]
- Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality: a cohort analysis. JAMA 1996; 275: 1489–1494, [INFOTRIEVE], [CSA], [CROSSREF]
- Toprak O, Cirit M, Bayata S, Yesil M. Review of the radiocontrast nephropathy risk profiles and risk stratification. Anadolu Kardiyol Derg. 2004; 4: 331–335, [INFOTRIEVE], [CSA]
- Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, Mintz GS, Lansky AJ, Moses JW, Stone GW, Leon MB, Dangas G. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004; 44: 1393–1399, [INFOTRIEVE], [CSA]
- Nikolsky E, Aymong ED, Dangas G, Mehran R. Radiocontrast nephropathy: identifying the high-risk patient and the implications of exacerbating renal function. Rev Cardiovasc Med. 2003; 4(Suppl.1)7–14, [CSA]
- Khanal S, Attallah N, Smith DE, Kline-Rogers E, Share D, O'Donnell MJ, Moscucci M. Statin therapy reduces contrast-induced nephropathy: an analysis of contemporary percutaneous interventions. Am J Med. 2005; 118: 843–849, [INFOTRIEVE], [CSA], [CROSSREF]
- Moore RD, Steinberg EP, Powe NR, Brinker JA, Fishman EK, Graziano S, Gopalan R. Nephrotoxicity of high-osmolarity vs low-osmolarity contrast media: randomized clinical trial. Radiology 1992; 182: 649–655, [INFOTRIEVE], [CSA]
- Barrett BJ, Parfrey PS, Vavasour HM, McDonald J, Kent G, Hefferton D, O'Dea F, Stone E, Reddy R, McManamon PJ. Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int. 1992; 41: 1274–1279, [INFOTRIEVE], [CSA]
- Weinrauch LA, Healy RW, Leland OS, Jr., Goldstein HH, Kassissieh SD, Libertino JA, Takacs FJ, D'Elia JA. Coronary angiography and acute renal failure in diabetic azotemic nephropathy. Ann Intern Med 1977; 86: 56–59, [INFOTRIEVE], [CSA]
- Asif A, Preston RA, Roth D. Radiocontrast-induced nephropathy. Am J Ther. 2003; 10: 137–147, [INFOTRIEVE], [CSA], [CROSSREF]
- Lautin EM, Freeman NJ, Schoenfeld AH, Bakal CW, Haramati N, Friedman AC, Lautin JL, Braha S, Kadish EG, Sprayregen S. Radiocontrast-associated renal dysfunction: incidence and risk factors. AJR Am J Roentgenol. 1991; 157: 49–58, [INFOTRIEVE], [CSA]
- Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, Farid N, McManamon PJ. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med. 1989; 320: 143–149, [INFOTRIEVE], [CSA]
- Jabs K, Zeidel ML, Silvia P. Prostaglandin E2 inhibits Na-K ATPase activity in the inner medullary collecting duct. Am J Physiol. 1989; 257: 424–430, [CSA]
- Kolonko A, Kokot F, Wiecek A. Contrast-associated nephropathy—old clinical problem and new therapeutic perspectives. Nephrol Dial Transplant. 1998; 13: 803–806, [INFOTRIEVE], [CSA], [CROSSREF]
- Weisbord SD, Palevsky PM. Radiocontrast-induced acute renal failure. J Intensive Care Med. 2005; 20: 63–75, [INFOTRIEVE], [CSA], [CROSSREF]
- Dudzinski PJ, Petrone AF, Persoff M, Callaghan EE. Acute renal failure following high dose excretory urography in dehydrated patients. J Urol. 1971; 106: 619–621, [INFOTRIEVE], [CSA]
- Katzberg RW. Contrast medium-induced nephrotoxicity: which pathway?. Radiology. 2005; 235: 752–755, [INFOTRIEVE], [CSA]
- Maeder M, Klein M, Fehr T, Rickli H. Contrast nephropathy: review focusing on prevention. J Am Coll Cardiol. 2004; 44: 1763–1771, [INFOTRIEVE], [CSA], [CROSSREF]
- Toprak O, Cirit M. Investigating the volume status before contrast nephropathy studies. Nephrol Dial Transplant. 2005; 20: 464, [INFOTRIEVE], [CSA], [CROSSREF]
- Toprak O, Cirit M, Bayata S, Aslan SL, Sarioglu F, Cetinkaya GS. Is there any relationship between left ventricul ejection fraction and contrast induced nephropathy?. Turkiye Klinikleri J Med Sci. 2003; 23: 104–107, [CSA]
- Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, Grines CL, O'Neill WW. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol. 2004; 93: 1515–1519, [INFOTRIEVE], [CSA], [CROSSREF]
- Sadeghi HM, Stone GW, Grines CL, Mehran R, Dixon SR, Lansky AJ, Fahy M, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Stuckey TD, Turco M, Carroll JD. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation. 2003; 108: 2769–2775, [INFOTRIEVE], [CSA], [CROSSREF]
- Iakovou I, Dangas G, Mehran R, Lansky AJ, Ashby DT, Fahy M, Mintz GS, Kent KM, Pichard AD, Satler LF, Stone GW, Leon MB. Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention. J Invasive Cardiol. 2003; 15: 18–22, [INFOTRIEVE], [CSA]
- Gruberg L, Mehran R, Dangas G, Mintz GS, Waksman R, Kent KM, Pichard AD, Satler LF, Wu H, Leon MB. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv. 2001; 52: 409–416, [INFOTRIEVE], [CSA], [CROSSREF]
- Prasad PV, Epstein FH. Changes in medullary pO2 during water diuresis as evaluated by blood oxygen level-dependent magnetic resonance imaging. Kidney Int. 1999; 55: 294–298, [INFOTRIEVE], [CSA], [CROSSREF]
- Kohli HS, Bhaskaran MC, Muthukumar T, Thennarasu K, Sud K, Jha V, Gupta KL, Sakhuja V. Treatment-related acute renal failure in the elderly: a hospital-based prospective study. Nephrol Dial Transplant. 2000; 15: 212–217, [INFOTRIEVE], [CSA], [CROSSREF]
- Kisley LR, Sakai RR, Flanagan-Cato LM, Fluharty SJ. Estrogen increases angiotensin II-induced c-Fos expression in the vasopressinergic neurons of the paraventricular nucleus in the female rat. Neuroendocrinology. 2000; 72: 306–317, [INFOTRIEVE], [CSA], [CROSSREF]
- McCullough PA, Sandberg KR. Epidemiology of contrast-induced nephropathy. Rev Cardiovasc Med. 2003; 4(Suppl. 5)3–9, [CSA]
- Cigarroa RG, Lange RA, Williams RH, Hillis LD. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med. 1989; 86: 649–652, [INFOTRIEVE], [CSA], [CROSSREF]
- Taliercio CP, Vlietstra RE, Fisher LD, Burnett JC. Risks for renal dysfunction with cardiac angiography. Ann Intern Med. 1986; 104: 501–504, [INFOTRIEVE], [CSA]
- Lin J, Bonventre JV. Prevention of radiocontrast nephropathy. Curr Opin Nephrol Hypertens. 2005; 14: 105–110, [INFOTRIEVE], [CSA]
- Chalmers N, Jackson RW. Comparison of iodixanol and iohexol in renal impairment. Br J Radiol. 1999; 72: 701–703, [INFOTRIEVE], [CSA]
- Baker CS, Wragg A, Kumar S, De Palma R, Baker LR, Knight CJ. A rapid protocol for the prevention of contrast-inducted renal dysfunction: the RAPPID Study. J Am Coll Cardiol. 2003; 41: 2114–2118, [INFOTRIEVE], [CSA]
- Stone GW, McCullough PA, Tumlin JA, Lepor NE, Madyoon H, Murray P, Wang A, Chu AA, Schaer GL, Stevens M, Wilensky RL, O'Neill WW. CONTRAST Investigators. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA. 2003; 290: 2284–2291, [INFOTRIEVE], [CSA]
- Liss P. Effects of contrast media on renal microcirculation and oxygen tension: an experimental study in the rat. Acta Radiol 1997; 409(Suppl.)1–29, [CSA]
- Soejima K, Uozumi J, Kanou T, Fujiyama C, Masaki Z. Nonionic contrast media are less nephrotoxic than ionic contrast media to rat renal cortical slices. Toxicol Lett. 2003; 143: 17–25, [INFOTRIEVE], [CSA], [CROSSREF]
- Mudge GH. Uricosuric action of cholecystographic agents: possible nephrotoxicity. N Engl J Med. 1971; 284: 929–933, [INFOTRIEVE], [CSA]
- Postlethwaite AE, Kelley WN. Uricosuric effect of radiocontrast agents: a study in man of four commonly used preparations. Ann Intern Med. 1971; 74: 845–852, [INFOTRIEVE], [CSA]
- Perlstein TS, Gumieniak O, Hopkins PN, Murphey LJ, Brown NJ, Williams GH, Hollenberg NK, Fisher ND. Uric acid and the state of the intrarenal renin-angiotensin system in humans. Kidney Int. 2004; 66: 1465–1470, [INFOTRIEVE], [CSA], [CROSSREF]
- Andrade L, Campos SB, Seguro AC. Hypercholesterolemia aggravates radiocontrast nephrotoxicity: protective role of arginine. Kidney Int. 1998; 53: 1736–1742, [INFOTRIEVE], [CSA], [CROSSREF]
- Yang DW, Jia RH, Yang DP, Ding GH, Huang CX. Dietary hypercholesterolemia aggravates contrast media-induced nephropathy. Chin Med J. 2004; 117: 542–546, [INFOTRIEVE], [CSA]
- Byrd L, Sherman RL. Radiocontrast-induced acute renal failure: a clinical and pathophysiologic review. Medicine. 1979; 58: 270–279, [INFOTRIEVE], [CSA]
- Weber-Mzell D, Kotanko P, Schumacher M, Klein W, Skrabal F. Coronary anatomy predicts presence or absence of renal artery stenosis: a prospective study in patients undergoing cardiac catheterization for suspected coronary artery disease. Eur Heart J. 2002; 23: 1684–1691, [INFOTRIEVE], [CSA]
- Ahuja TS, Niaz N, Agraharkar M. Contrast-induced nephrotoxicity in renal allograft recipients. Clin Nephrol. 2000; 54: 11–14, [INFOTRIEVE], [CSA]
- Holland MD, Galla JH, Sanders PW, Luke RG. Effect of urinary pH and diatrizoate on Bence Jones protein nephrotoxicity in the rat. Kidney Int. 1985; 27: 46–50, [INFOTRIEVE], [CSA]
- McCarthy CS, Becker JA. Multiple myeloma and contrast media. Radiology. 1992; 183: 519–521, [INFOTRIEVE], [CSA]
- Vuong TD, Braam B, Willekes-Koolschijn N, Boer P, Koomans HA, Joles JA. Hypoalbuminemia enhances the renal vasoconstrictor effect of lysophosphatidylcholine. Nephrol Dial Transplant. 2003; 18: 1485–1492, [INFOTRIEVE], [CSA], [CROSSREF]
- Nawaz S, Cleveland T, Gaines PA, Chan P. Clinical risk associated with contrast angiography in metformin treated patients: a clinical review. Clin Radiol. 1998; 53: 342–344, [INFOTRIEVE], [CSA], [CROSSREF]
- Nikolsky E, Mehran R, Lasic Z, Mintz GS, Lansky AJ, Na Y, Pocock S, Negoita M, Moussa I, Stone GW, Moses JW, Leon MB, Dangas G. Low hematocrit predicts contrast-induced nephropathy after percutaneous coronary interventions. Kidney Int. 2005; 67: 706–713, [INFOTRIEVE], [CSA], [CROSSREF]
- Ide JM, Lancelot E, Pines E, Corot C. Prophylaxis of iodinated contrast media-induced nephropathy: a pharmacological point of view. Invest Radiol. 2004; 39: 155–170, [INFOTRIEVE], [CSA]
- Asif A, Epstein M. Prevention of radiocontrast-induced nephropathy. Am J Kidney Dis. 2004; 44: 12–24, [INFOTRIEVE], [CSA], [CROSSREF]
- Mueller C, Buerkle G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, Marsch S, Roskamm H. Prevention of contrast media-associated nephropathy: randomized comparison of two hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med. 2002; 162: 329–336, [INFOTRIEVE], [CSA], [CROSSREF]
- Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, Bersin RM, Van Moore A, Simonton CA III, Rittase RA, Norton HJ, Kennedy TP. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA. 2004; 291: 2328–2334, [INFOTRIEVE], [CSA], [CROSSREF]
- Mueller C, Seidensticker P, Buettner HJ, Perruchoud AP, Staub D, Christ A, Buerkle G. Incidence of contrast nephropathy in patients receiving comprehensive intravenous and oral hydration. Swiss Med Wkly. 2005; 135: 286–290, [INFOTRIEVE], [CSA]
- Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 1994; 331: 1416–1420, [INFOTRIEVE], [CSA], [CROSSREF]
- Tepel M, van Der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000; 343: 180–184, [INFOTRIEVE], [CSA], [CROSSREF]
- Drager LF, Andrade L, Barros de Toledo JF, Laurindo FR, Machado Cesar LA, Seguro AC. Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury. Nephrol Dial Transplant. 2004; 19: 1803–1807, [INFOTRIEVE], [CSA], [CROSSREF]
- Diaz-Sandoval LJ, Kosowsky BD, Losordo DW. Acetylcysteine to prevent angiography-related renal tissue injury (The APART Trial). Am J Cardiol. 2002; 89: 356–358, [INFOTRIEVE], [CSA], [CROSSREF]
- Birck R, Krzossok S, Markowetz F, Schnulle P, van der Woude FJ, Braun C. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet. 2003; 362: 598–603, [INFOTRIEVE], [CSA], [CROSSREF]
- Liu R, Nair D, Ix J, Moore DH, Bent S. N-acetylcysteine for the prevention of contrast-induced nephropathy: a systematic review and meta-analysis. J Gen Intern Med. 2005; 20: 193–200, [INFOTRIEVE], [CSA], [CROSSREF]
- Briguori C, Manganelli F, Scarpato P, Elia PP, Golia B, Riviezzo G, Lepore S, Librera M, Villari B, Colombo A, Ricciardelli B. Acetylcysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol. 2002; 40: 298–303, [INFOTRIEVE], [CSA], [CROSSREF]
- Gomes VO, Poli de Figueredo CE, Caramori P, Lasevitch R, Bodanese LC, Araujo A, Roedel AP, Caramori AP, Brito FS, Jr.Bezerra HG, Nery P, Brizolara A. N-acetylcysteine does not prevent contrast induced nephropathy after cardiac catheterization with an ionic low osmolality contrast medium: a multicentre clinical trial. Heart. 2005; 91: 774–778, [INFOTRIEVE], [CSA], [CROSSREF]
- Gulel O, Keles T, Eraslan H, Aydogdu S, Diker E, Ulusoy V. Prophylactic acetylcysteine usage for prevention of contrast nephropathy after coronary angiography. J Cardiovasc Pharmacol. 2005; 46: 464–467, [INFOTRIEVE], [CSA], [CROSSREF]
- Tietz NW. Clinical guide to laboratory tests. General Clinical Tests 3rd, NW Tietz. WB Saunders Company, Philadelphia 1995; 186–187
- Hoffmann U, Fischereder M, Kruger B, Drobnik W, Kramer BK. The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol. 2004; 15: 407–410, [INFOTRIEVE], [CSA], [CROSSREF]
- Spargias K, Alexopoulos E, Kyrzopoulos S, Iokovis P, Greenwood DC, Manginas A, Voudris V, Pavlides G, Buller CE, Kremastinos D, Cokkinos DV. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation. 2004; 110: 2837–2842, [INFOTRIEVE], [CSA], [CROSSREF]
- Madyoon H, Croushore L, Weaver D, Mathur V. Use of fenoldopam to prevent radiocontrast nephropathy in high-risk patients. Catheter Cardiovasc Interv. 2001; 53: 341–345, [INFOTRIEVE], [CSA], [CROSSREF]
- Tumlin JA, Wang A, Murray PT, Mathur VS. Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy. Am Heart J. 2002; 143: 894–903, [INFOTRIEVE], [CSA], [CROSSREF]
- Allaqaband S, Tumuluri R, Malik AM, Gupta A, Volkert P, Shalev Y, Bajwa TK. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Catheter Cardiovasc Interv. 2002; 57: 279–283, [INFOTRIEVE], [CSA], [CROSSREF]
- Briguori C, Colombo A, Airoldi F, Violante A, Castelli A, Balestrieri P, Paolo Elia P, Golia B, Lepore S, Riviezzo G, Scarpato P, Librera M, Focaccio A, Ricciardelli B. N-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicity. J Am Coll Cardiol. 2004; 18: 762–765, [CSA], [CROSSREF]
- Erley CM, Duda SH, Rehfuss D, Scholtes B, Bock J, Muller C, Osswald H, Risler T. Prevention of radiocontrast media-induced nephropathy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline. Nephrol Dial Transplant. 1999; 14: 1146–1149, [INFOTRIEVE], [CSA], [CROSSREF]
- Kapoor A, Kumar S, Gulati S, Gambhir S, Sethi RS, Sinha N. The role of theophylline in contrast-induced nephropathy: a case-control study. Nephrol Dial Transplant. 2002; 17: 1936–1941, [INFOTRIEVE], [CSA], [CROSSREF]
- Rodicio JL, Morales JM, Ruilope LM. Calcium antagonists and the kidney. Nephrol Dial Transplant. 1990; 5: 81–86, [INFOTRIEVE], [CSA]
- Russo D, Testa A, Della Volpe L, Sansone G. Randomized prospective study on renal effects of two different contrast media in humans: protective role of a calcium channel blocker. Nephron. 1990; 55: 254–257, [INFOTRIEVE], [CSA]
- Neumayer HH, Junge W, Kufner A, Wening A. Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: a prospective randomized clinical trial. Nephrol Dial Transplant. 1989; 4: 1030–1036, [INFOTRIEVE], [CSA]
- Spangberg-Viklund B, Berglund J, Nikonoff T, Nyberg P, Skau T, Larsson R. Does prophylactic treatment with felodipine, a calcium antagonist, prevent low-osmolar contrast-induced renal dysfunction in hydrated diabetic and nondiabetic patients with normal or moderately reduced renal function?. Scand J Urol Nephrol. 1996; 30: 63–68, [INFOTRIEVE], [CSA]
- Caldicott WJ, Hollenberg NK, Abrams HL. Characteristics of response of renal vascular bed to contrast media: evidence for vasoconstriction induced by renin-angiotensin system. Invest Radiol. 1970; 5: 539–547, [INFOTRIEVE], [CSA]
- Workman RJ, Shaff MI, Jackson RV, Diggs J, Frazer MG, Briscoe C. Relationship of renal hemodynamic and functional changes following intravascular contrast to the renin-angiotensin system and renal prostacyclin in the dog. Invest Radiol. 1983; 18: 160–166, [INFOTRIEVE], [CSA]
- Gupta RK, Kapoor A, Tewari S, Sinha N, Sharma RK. Captopril for preventing of contrast-induced nephropathy in diabetic patients: a randomized study. Indian Heart J. 1999; 51: 521–526, [INFOTRIEVE], [CSA]
- Toprak O, Cirit M, Bayata S, Yesil M, Aslan LS. The effect of pre-procedural captopril on contrast media induced nephropathy who underwent coronary angiography. Anadolu Kardiyol Derg. 2003; 3: 98–103, [INFOTRIEVE], [CSA]
- Koch JA, Plum J, Grabensee B, Modder U. Prostaglandin E1: a new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media?. Nephrol Dial Transplant. 2000; 15: 43–49, [INFOTRIEVE], [CSA], [CROSSREF]
- Weisberg LS, Kurnik PB, Kurnik BR. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int. 1994; 45: 259–265, [INFOTRIEVE], [CSA]
- Kurnik BR, Allgren RL, Genter FC, Solomon RJ, Bates ER, Weisberg LS. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis. 1998; 31: 674–680, [INFOTRIEVE], [CSA]
- Liss P, Carlsson PO, Nygren A, Palm F, Hansell P. ET-A receptor antagonist BQ123 prevents radiocontrast media-induced renal medullary hypoxia. Acta Radiologica. 2003; 44: 111–117, [INFOTRIEVE], [CSA], [CROSSREF]
- Wang A, Holcslaw T, Bashore TM, Freed MI, Miller D, Rudnick MR, Szerlip H, Thames MD, Davidson CJ, Shusterman N, Schwab SJ. Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism. Kidney Int. 2000; 57: 1675–1680, [INFOTRIEVE], [CSA]
- Kapoor A, Sinha N, Sharma RK, Shrivastava S, Radhakrishnan S, Goel PK, Bajaj R. Use of dopamine in prevention of contrast induced acute renal failure: a randomized study. Int J Cardiol. 1996; 53: 233–236, [INFOTRIEVE], [CSA]
- Hans SS, Hans BA, Dhillon R, Dmuchowski C, Glover J. Effect of dopamine on renal function after arteriography in patients with preexisting renal insufficiency. Am Surg. 1998; 34: 1682–1688, [CSA]
- Abizaid AS, Clark CE, Mintz GS, Dosa S, Popma JJ, Pichard AD, Satler LF, Harvey M, Kent KM, Leon MB. Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency. Am J Cardiol. 1999; 83: 260–263, [INFOTRIEVE], [CSA], [CROSSREF]
- Vogt B, Ferrari P, Schonholzer C, Marti HP, Mohaupt M, Wiederkehr M, Cereghetti C, Serra A, Huynh-Do U, Uehlinger D, Frey FJ. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med. 2001; 111: 692–698, [INFOTRIEVE], [CSA], [CROSSREF]
- Marenzi G, Marana I, Lauri G, Assanelli E, Grazi M, Campodonico J, Trabattoni D, Fabbiocchi F, Montorsi P, Bartorelli AL. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med. 2003; 349: 1333–1340, [INFOTRIEVE], [CSA], [CROSSREF]
- Thomsen HS. How to avoid CIN: guidelines from the European Society of Urogenital Radiology. Nephrol. Dial. Transplant. 2005; 20: 18–22, [CSA], [CROSSREF]
- Hoffmann U, Fischereder M, Reil A, Fischer M, Link J, Kramer BK. Renal effects of gadopentetate dimeglumine in patients with normal and impaired renal function. Eur J Med Res. 2005; 10: 149–154, [INFOTRIEVE], [CSA]
- Ergun I, Keven K, Uruc I, Ekmekci Y, Canbakan B, Erden I, Karatan O. The safety of gadolinium in patients with stage 3 and 4 renal failure. Nephrol Dial Transplant. 2006; 21: 697–700, [INFOTRIEVE], [CSA], [CROSSREF]
- Erley CM, Bader BD, Berger ED, Tuncel N, Winkler S, Tepe G, Risler T, Duda S. Gadolinium-based contrast media compared with iodinated media for digital subtraction angiography in azotaemic patients. Nephrol Dial Transplant. 2004; 19: 2526–2531, [INFOTRIEVE], [CSA], [CROSSREF]
- Jakobsen JA, Oyen R, Thomsen HS, Morcos SK, Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). Safety of ultrasound contrast agents. Eur Radiol. 2005; 15: 941–945, [INFOTRIEVE], [CSA], [CROSSREF]